Episode

Advancing KRAS G12C-Targeted Therapies in NSCLC: Current Evidence and Future Directions

Podcast: Decera Clinical Education Oncology Podcast
Published: Mar 9, 2026
Duration seconds: 1004
Processing state: not_requested
Canonical source: https://oncologypodcast.simplecast.com/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions-b5W8lj1w
Audio: https://afp-928689-injected.calisto.simplecastaudio.com/1d8e143b-904e-45be-b6c5-8fba793d9d74/episodes/f66e748b-9c41-4a1f-b7ad-ef0bbde021f4/audio/128/default.mp3?aid=rss_feed&awCollectionId=1d8e143b-904e-45be-b6c5-8fba793d9d74&awEpisodeId=f66e748b-9c41-4a1f-b7ad-ef0bbde021f4&feed=GlfUTtJq
JSON: /v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions
Markdown: /podcast/decera-clinical-education-oncology-podcast-1302999/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions.md

Actions

POST https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, 2 experts discuss the evolving role of KRAS G12C inhibitors in non-small-cell lung cancer (NSCLC), including the clinical impact of first-generation therapies and challenges related to resistance. They also explore emerging next-generation inhibitors and combination strategies that may expand treatment options and improve patient outcomes.